JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120711

Metoprolol tartrate, beta1 Adrenoceptor antagonist

Be the first to review this product! Submit a review

|

(3 Publications)

MW 342.41 g/mol, Purity >99%. β1 Adrenoceptor antagonist (Ki values are 47, 2960 and 10100 nM for β1, β2 and β3, respectively). Systemically active following oral administration.
1 Images
Chemical Structure - Metoprolol tartrate, beta1 Adrenoceptor antagonist (AB120711)
  • Chemical Structure

Lab

Chemical Structure - Metoprolol tartrate, beta1 Adrenoceptor antagonist (AB120711)

2D chemical structure image of ab120711, Metoprolol tartrate, beta1 Adrenoceptor antagonist

Key facts

CAS number

56392-17-7

Purity

>99%

Form

Solid

form

Molecular weight

342.41 g/mol

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Soluble in DMSO to 100 mM

Biological description

β1 Adrenoceptor antagonist (Ki values are 47, 2960 and 10100 nM for β1, β2 and β3, respectively). Systemically active following oral administration.

IUPAC Name

1-[4-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol hemitartrate

style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
style
left-column
style
left-column
style
left-column

Product protocols

style
left-column

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Cell stem cell 30:86-95.e4 PubMed36563695

2022

A deep learning platform to assess drug proarrhythmia risk.

Applications

Unspecified application

Species

Unspecified reactive species

Ricardo Serrano,Dries A M Feyen,Arne A N Bruyneel,Anna P Hnatiuk,Michelle M Vu,Prashila L Amatya,Isaac Perea-Gil,Maricela Prado,Timon Seeger,Joseph C Wu,Ioannis Karakikes,Mark Mercola

Cells 11: PubMed35011613

2021

The Anti-Inflammatory Effect of the β1-Adrenergic Receptor Antagonist Metoprolol on High Glucose Treated Human Microvascular Retinal Endothelial Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Giovanni Giurdanella,Anna Longo,Alfio Distefano,Melania Olivieri,Martina Cristaldi,Alessia Cosentino,Aleksandra Agafonova,Nunzia Caporarello,Gabriella Lupo,Carmelina Daniela Anfuso

Journal of cellular biochemistry 120:17872-17886 PubMed31161623

2019

β-Adrenoceptor signaling regulates proliferation and contraction of human bladder smooth muscle cells under pathological hydrostatic pressure.

Applications

Unspecified application

Species

Unspecified reactive species

Junyu Lai,Jianzhong Ai,Deyi Luo,Tao Jin,Banghua Liao,Liang Zhou,Shijian Feng,Xi Jin,Hong Li,Kunjie Wang
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB92547

Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker

BOND RX™ Validated|KO Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Multiplex immunohistochemistry - Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (AB92547)

  • 5
  • 92
Biochemicals

AB120440

NECA, adenosine agonist

Chemical Structure - NECA, adenosine agonist (AB120440)

  • 0
  • 0
Primary Antibodies

AB64457

Anti-Mineralocorticoid Receptor antibody

BOND RX™ Validated

Immunocytochemistry/ Immunofluorescence - Anti-Mineralocorticoid Receptor antibody (AB64457)

  • 3
  • 2
Biochemicals

AB146724

Isoprenaline hydrochloride (Isoproterenol) (mM/ml), beta adrenoceptor agonist

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com